Pharma & Healthcare
The pharma & life science sector is characterised by long start-up periods, major investments and uncertainty regarding whether innovations will actually make it to market launch. Moreover, these long and complex processes are highly regulated. Protection of intellectual property, IT security and the integrity of employees are important priorities for players in the pharmaceutical sector.
Healthcare is also undergoing major changes. There are fewer financial options from the public sector than there had been previously, and the population is ageing.Healthcare is slowly moving towards thinking and acting in a market-oriented manner. Hospitals and other institutions in the healthcare sector are expected to be transparent regarding the costs and income of their organisations. This demands a different organisational structure, which goes hand in hand with investments in knowledge, people and systems.